Total raised
—
Last: Undisclosed 2020-02
Stage
Seed
Founded
2019
Headcount
1
HQ
Magshimim
Sector
Health Tech & Life Sciences
About
Curesign is a medical device company aiming to disrupt the way oncologists treat patients with cancer. The companys solution is based on the integration of sensors with advanced signal-processing and big data tools. Curesigns product, which is in the advanced stages of development, is designed to allow clinical teams to tailor a patient-specific treatment for each cancer patient. Curesigns technology has been successfully demonstrated in preclinical studies. Based on the results, the company is currently working on a commercial product for use in many preclinical trials in the field of oncology.
Funding history · 1 round · — total
2020-02
Undisclosed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsDigital HealthcareMedical Decision Support
Technologies
SensingArtificial Intelligence
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
big-datacancer-therapycancermedical-devicesoncologysensorssignal-processing